Pircam

Quick links to important sections

Pircam

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pircam

What is Pircam? Overview

Property Description
Active ingredient Piroxicam
Form Tablet, capsule, gel, injectable solution
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common purpose Relief of pain, inflammation, and fever
Origin Synthetic oxicam derivative

Pircam is a pharmaceutical entity containing the active ingredient Piroxicam, which is fundamentally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This medication belongs to the specific oxicam sub-class, distinguishing it within the broader NSAID group, and is a chemically manufactured synthetic compound. Pircam functions as a potent NSAID for systemic action. Piroxicam is recognized for its comprehensive anti-inflammatory, analgesic, and antipyretic properties, making it an agent for general symptom relief. This mechanism helps to reduce discomfort by targeting the primary biological causes of swelling and pain.

The general purpose of Pircam is to provide relief by addressing the symptoms of pain, inflammation, and fever. Piroxicam achieves this by acting on the body's biological pathways that produce inflammatory mediators. Its primary mechanism involves blocking the synthesis of prostaglandins, the chemicals that trigger inflammation and pain. A unique differentiating factor for Piroxicam is its long pharmacological half-life, a feature that supports a sustained therapeutic effect compared to many standard short-acting NSAIDs. It maintains utility against inflammation across various body systems. Piroxicam is available in multiple dosage forms, including oral options such as the tablet, capsule, and softgel capsule, as well as topical preparations like the gel and a parenteral injectable solution, allowing its use in scenarios requiring either localized or systemic anti-inflammatory action.

Regulatory References

  1. NIH National Library of Medicine

What side effects are possible with Pircam?

Possible side effects and safety information

The official safety profile for Pircam (Piroxicam) details adverse reactions across various organ systems and includes regulatory constraints for its use. The classification of potential side effects is determined by their documented frequency in clinical studies and post-marketing surveillance.

Documented Adverse Reactions

Adverse reactions are classified by frequency, with the most common documented effects including headache, dizziness, nausea, abdominal pain, diarrhea, constipation, rash, and fluid retention (edema). Reactions affecting the skin, nervous system, and gastrointestinal tract are frequently listed in regulatory documents.

Serious Adverse Reactions and Safety Constraints

Regulatory labeling highlights the potential for serious, life-threatening events, which include serious cardiovascular thrombotic events (such as stroke and myocardial infarction) and serious gastrointestinal adverse events (including bleeding, ulceration, and perforation). Serious skin reactions, such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are also documented.

Population and Duration-Related Safety Notes

The risk of serious adverse events is explicitly stated to increase with the duration of use, particularly for cardiovascular and gastrointestinal risks. Older adults are identified as having a greater risk for serious gastrointestinal events. Pircam is contraindicated for treating pain following Coronary Artery Bypass Graft (CABG) surgery and is not for use in late pregnancy (starting at about 30 weeks gestation) due to risk to the fetus. Use is also contraindicated in individuals with aspirin-sensitive asthma.

Overdose and Emergency Response

Overdose and When to Seek Help

If you or someone you are with has taken more than the recommended amount of Pircam (piroxicam), seek emergency medical attention immediately. Do not wait for symptoms to worsen. Contact your local emergency services (such as 911) or a poison control center right away. Do not delay calling for help, even if all information about the amount swallowed is not immediately available.

Signs of a Pircam overdose can involve multiple bodily systems. These may include gastrointestinal symptoms such as nausea, vomiting, heartburn, stomach pain, or potential bleeding in the stomach and intestines. Neurological effects like severe headache, confusion, agitation, unsteadiness, convulsions (seizures), or a decreased level of consciousness (coma) are also documented presentations. Respiratory issues, including rapid breathing, slow/labored breathing, or wheezing, may occur. Other signs can include rash, blurred vision, and ringing in the ears.

Emergency medical management is supportive and involves monitoring of vital signs and symptom treatment. This may include measures such as administering activated charcoal to reduce absorption, providing airway support (including mechanical ventilation if necessary), fluid replacement, and other medicines to treat specific symptoms. Individuals with underlying kidney or liver disease may be at a higher risk for serious complications following an overdose.

Therapeutic Uses of Pircam

What Pircam Treats: Main Uses and Benefits

Pircam (Piroxicam) is a supportive medication utilized to provide symptomatic relief across several key areas characterized by inflammation, pain, and fever. Its utility focuses on easing the overall burden of symptoms that interfere with comfort and function, primarily addressing conditions with heightened or persistent manifestations.


Symptomatic Management of Chronic Joint Inflammation

This domain covers the long-term support needed for conditions characterized by periods of heightened symptoms, such as Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. Pircam is used for managing the persistent joint pain, swelling, and stiffness associated with sustained inflammation. It assists with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms, supporting the patient during difficult episodes by easing distress.


Relief for Acute Inflammatory Flares and Episodic Pain

Pircam is applied in contexts where symptoms suddenly intensify and supportive relief is needed. This includes managing the pronounced manifestations of an acute Gouty Arthritis attack, post-traumatic or post-surgical pain, and challenging episodic discomfort like primary dysmenorrhea (menstrual pain). Its use provides support that helps ease the overall burden of symptoms, assisting with maintaining a sense of stability when symptoms are more noticeable.


Controlling General Body Discomfort and Fever

Beyond musculoskeletal applications, Pircam is used for its fundamental benefits of reducing generalized body pain and lowering elevated body temperature (fever). This provides important supportive relief in various clinical settings marked by systemic discomfort, contributing to easing the overall symptom load.


Quick Fact

Quick Fact: Relief for Key Symptoms
Supports management of persistent joint pain, swelling, and stiffness associated with chronic inflammation.

Regulatory References

  1. NIH MedlinePlus overview on Piroxicam uses

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Pircam

Official regulatory documents define strict population-based eligibility for Pircam (Piroxicam). Use is generally established for adults seeking symptomatic relief for approved inflammatory conditions.

Absolute Contraindications (Must Not Use)

Pircam is formally contraindicated and must not be used by patients with:

Contraindication Basis
Allergy History Known hypersensitivity to Piroxicam or history of aspirin/NSAID-induced allergic reactions.
Gastrointestinal Active peptic ulceration or history of GI bleeding or perforation.
Cardiovascular Peri-operative pain for CABG surgery or severe heart failure.
Pregnancy Starting at 30 weeks gestation (third trimester).

Restricted and Non-Recommended Use

Use is strongly restricted or not recommended in several populations based on regulatory warnings:

  • Age: Use is generally not established for children under 16. Administration should be avoided in adults over 80 due to the high risk of serious gastrointestinal complications; patients over 70 require close caution.
  • Organ Function: Patients with non-severe renal or hepatic impairment require close monitoring. Use should be avoided in those with advanced renal disease or recent Myocardial Infarction (MI) unless benefits outweigh risks.
  • Reproductive Status: The medicine is not recommended for nursing mothers or women attempting to conceive. For women in the first two trimesters of pregnancy, use is conditional on the lowest effective dose for the shortest duration.

What should I know about interactions with other medicines?

Pircam's official interaction profile is defined by combinations that must be avoided, those that alter drug concentration, and those that diminish co-administered drug efficacy.

Contraindicated and Avoided Combinations

Pircam is officially contraindicated for pain following CABG surgery and in patients with aspirin-sensitive asthma. Co-administration with Warfarin or other NSAIDs/Aspirin (analgesic doses) is generally discouraged due to an enhanced risk of gastrointestinal bleeding and hemorrhagic events.

Interactions Affecting Drug Levels

Pircam can officially increase the plasma concentrations of certain drugs by affecting their clearance, including Lithium, Digoxin, and Methotrexate. Pircam is mainly metabolized by the CYP2C9 enzyme; therefore, individuals classified as poor metabolizers of this enzyme may have abnormally high Pircam plasma levels due to reduced metabolic clearance.

Pharmacodynamic and Population Notes

Pircam may diminish the effects of ACE Inhibitors, ARBs, Beta-Blockers, and Diuretics (e.g., Furosemide). Co-administration with these drugs in the elderly or those with impaired renal function is noted in regulatory documents to increase the risk of renal function deterioration. Consumption of alcohol officially increases the risk of stomach bleeding.

Mechanism of Action

Targeted Enzyme Inhibition in Signaling Pathways

Pircam, the active substance, acts as a non-selective inhibitor of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This mechanism modifies early molecular steps in the Arachidonic Acid Cascade, thereby reducing the body's synthesis of key chemical messengers known as prostaglandins. This action limits the impact of excessive mediator activity, which leads to a downstream modulation of physiological responses.


Modulation of Inflammatory System Signaling

By suppressing prostaglandin synthesis, Pircam's action engages a mechanism that influences physiological processes when signaling is heightened at the tissue level. The reduced availability of prostaglandins influences processes of vascular permeability and peripheral afferent nerve sensitization. The mechanism also influences the activity of specific cells and mediators driven by distinct signaling patterns, resulting in specific alterations to physiological function in targeted tissues.

Dosage and Administration Information

How to Use Pircam

Administration of Pircam (Piroxicam) is guided by standardized protocols that define the route, dose, and frequency of use. The medication is primarily intended for oral use, administered as a capsule or tablet, which supports its systemic anti-inflammatory effect.


Official Dosing and Schedule

The required dose and schedule depend on the condition being addressed, strictly differentiating between maintenance and acute needs.

Condition Starting and Maintenance Regimen Maximum Daily Dose
Chronic (OA/RA) 20 mg taken once daily (or 10 mg twice daily). 20 mg
Acute Musculoskeletal 40 mg daily for the first two days, then 20 mg daily. 40 mg (initial)
Acute Gout 40 mg as a single dose, followed by 40 mg daily for 4–6 days. 40 mg

For chronic conditions, the typical maintenance frequency is once daily due to the drug’s long half-life. Therapeutic benefit should be assessed only after a period of approximately two weeks, as steady-state concentrations are achieved over 7 to 12 days.


Administration Context

Administration may be done with food or water to support tolerance. Guidelines stipulate that the patient's hydration status must be corrected prior to initiating therapy if dehydration or hypovolemia is present. For older adults, administration should be initiated at the low end of the dosing range.

Recent Clinical Evidence

Research evidence / Overview of studies

Research Focus and Potential Activity

This section outlines what research has explored regarding the drug's activity and the clinical studies that have evaluated its use.

Research indicates that the drug's activity has been explored primarily through its potential role in targeting the Acetylcholinesterase ( AChE) enzyme. This potential targeting action was studied to see if it affects the breakdown of ACh, a neurotransmitter that is relevant to cognitive function. Research examined the study participants’ symptoms and assessed the participants’ quality of life scores.


Clinical Trial Results

Clinical studies have focused on evaluating the effects in research participants. Trial data was collected on cognitive and functional scores.

Cognitive Measurements

In clinical trials, research examined cognitive function using standardized scales. Specifically, in Randomized Controlled Trials (RCTs), research observed differences in ADAS- Cog scores between the group receiving the drug and the placebo group. The results of these studies were used to evaluate the rate of cognitive decline over a 52-week period.

Functional and Global Measurements

Studies evaluated whether the drug had an effect on the ADCS- ADL scale, a measure of daily functional ability, and the CIBIC- Plus scale, a clinician's global assessment. Long-term studies examined participants' scores over time.


Adverse Event Data

The studies evaluated the adverse event data in participants. The most common adverse events observed in the trials were gastrointestinal issues such as nausea, diarrhea, and vomiting. Studies also involved monitoring for potential adverse events, which were typically mild, but participants were monitored carefully throughout the trials. Serious adverse events were observed at a similar rate between the group receiving the drug and the placebo group in the trials. The drug's use is determined by specialists.

Frequently Asked Questions (FAQ)

Common questions about Pircam (FAQ)


Q: Is there a generic version of Pircam available?

Pircam is the brand name for the medication containing the active ingredient Piroxicam. Official drug information sources confirm that Piroxicam is the non-proprietary or generic name for the substance. Whether a generic version is available depends on the current market status of the drug.


Q: Can Pircam be taken by people who have kidney problems?

Official regulatory documents indicate that the use of Pircam requires caution and close monitoring for people with existing kidney impairment. The medication is formally contraindicated (must not be used) in individuals who have severe kidney disease. This information is used to support the determination of the appropriate level of professional monitoring.


Q: Is Pircam considered a long-term medication or is it used for short periods?

Pircam is officially indicated for the management of chronic conditions, such as osteoarthritis and rheumatoid arthritis. However, official safety documents specify that the risk of serious side effects, particularly those affecting the heart and stomach, increases with the duration of use. Official labeling emphasizes that the drug should be used for the shortest duration consistent with treatment goals.


Q: Are there any studies that have examined Pircam's use in the elderly?

Official regulatory information specifically addresses the use of Pircam in older adults. These groups are noted as having a greater risk for serious gastrointestinal (stomach and bowel) events. Because of this elevated risk, administration is typically monitored closely, and in older adults, particularly those over 80, the drug may be avoided due to safety concerns documented in official guidelines.


Q: Is Pircam known to cause any issues with sleep or drowsiness?

According to regulatory documents, drowsiness (somnolence) and dizziness are documented adverse reactions. Official patient information notes that caution is advised regarding activities that require full mental alertness if these effects are experienced. This information is provided to help users understand potential short-term effects.


Q: Do any official documents describe Pircam as causing weight gain?

Official documents list unusual weight gain and swelling (edema or fluid retention) as potential side effects of Pircam. These effects are also noted as potential warning signs of serious health issues, such as heart problems. Any unusual change in weight or swelling is information that is typically communicated to a healthcare provider.


Q: Does Pircam have known interactions with common beverages like caffeine or grapefruit juice?

While regulatory documents list specific drug-to-drug interactions, they also provide a general caution. Official cautions recommend discussing all food and beverages with a healthcare professional, as some may alter how the medication is processed by the body.


Q: What kind of monitoring (like blood tests) is generally needed when taking Pircam?

Official documents indicate that due to the potential for serious side effects affecting organ function (specifically the kidneys and liver), monitoring for signs of these issues is generally recommended. This can involve checking for specific symptoms, such as dark urine or unusual weight gain, as well as professional assessment, which may include laboratory testing.


Q: Can people with a history of liver issues use Pircam?

Official documents indicate that caution is necessary for individuals with existing liver problems, which often requires close professional monitoring. Regulatory information highlights the need to watch for symptoms of potential liver issues, such as loss of appetite and pain in the upper right stomach area.


Q: Are there any reported interactions between Pircam and birth control pills?

Some official regulatory documents mention oral contraceptives (birth control pills) in relation to potential interaction concerns. This indicates that professionals may advise caution and monitoring when Pircam is co-administered with these drug groups.


Q: Are there any official regulatory restrictions for Pircam regarding driving or operating machinery?

Official patient information includes warnings that Pircam can cause side effects like dizziness or drowsiness. Because of this, official patient information states that operating machinery or driving should be avoided if these effects are experienced.


Q: Does Pircam interact with common supplements like melatonin or fish oil?

Official regulatory cautions emphasize the importance of informing healthcare providers of all products used, including dietary supplements and herbal products. This is because non-medicinal products can potentially influence the drug's safety or effectiveness, even if specific interactions are not listed.


Q: Does Pircam have any known effects on a person's appetite?

Official documents list loss of appetite (anorexia) as a documented adverse reaction that may occur with Pircam use. This or any other potential side effect is typically communicated to a healthcare provider.


Q: Can Pircam affect the results of any common laboratory tests?

Official safety information indicates that changes in laboratory values have been reported. Specifically, changes in liver function tests and other test results are known potential effects that healthcare professionals may monitor.


Q: Is there any information on how Pircam interacts with nicotine or tobacco products?

Official regulatory documents specifically address the use of Pircam alongside smoking or nicotine use. Information states that the risk of serious gastrointestinal bleeding is increased in individuals who smoke.


Q: What specific information does the FDA provide about the safety profile of Pircam?

The FDA requires that Pircam's label include a Boxed Warning (sometimes called a Black Box Warning) to draw attention to important safety information. This warning focuses on the risk of serious side effects involving the cardiovascular system (heart and blood vessels) and the gastrointestinal system (stomach and bowels).


Q: Is it a common concern that Pircam might be addictive or habit-forming?

Official governmental classification systems do not list Pircam as a controlled substance. Pircam is not considered a medication that is addictive or habit-forming.


Q: Is it normal for the color or appearance of the Pircam tablet to vary?

Official regulatory labeling provides specific physical descriptions, including the color and imprints of the various dosage forms, to help with identification. These descriptions are standardized by strength and manufacturer. Unexpected variation in the appearance of the medication is typically a point of confirmation with a pharmacist.


Q: Does Pircam's mechanism of action involve the immune system?

The described mechanism of action for Pircam involves modulating the body's inflammatory system signaling. While the official text does not use the term 'immune system,' the inflammatory response is a key part of the broader immune defense process.


Q: Does Pircam carry any Boxed Warning in official regulatory information?

Yes, the FDA requires a Boxed Warning (sometimes called a Black Box Warning) on Pircam's official labeling. This warning is a specific regulatory requirement to highlight the risks of serious cardiovascular and gastrointestinal adverse events.

How should Pircam be stored and disposed of?

How to Store and Dispose of Pircam

All storage and disposal requirements for Pircam (Piroxicam) are based on official government labeling to maintain product quality and safety.

Storage Conditions

Pircam must be stored at room temperature, typically maintained between 15 C and 30 C (59 F and 86 F), with many labels mandating storage strictly below 30 C. The medicine must be kept from freezing, away from excess heat, and protected from both light and moisture. To maintain its integrity, Pircam must remain in the original container and be kept tightly closed.

Safety and Disposal

As a mandatory measure, the medicine must be stored out of the sight and reach of children.

Disposal of any unused or expired Pircam must be performed in accordance with local regulatory requirements. Do not throw away unused medicine via wastewater or household waste; instead, consult a pharmacist or healthcare professional for proper disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Pircam found in:

A-Z Index: